Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Chim

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Leukemia|March 8, 2019
Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Leukemia|December 20, 2017
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Annals of Hematology|April 30, 2010
A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myelomaC S Chim, A K W Lie, E Y T Chan, et al.
Hematological Oncology|July 22, 1999
Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia: a single-centre experienceW Y Au, A K Lie, S K Ma, et al.
Chinese Medical Journal|June 1, 1997
Unrelated marrow donor registry for ChineseR Liang, C K Lee, F Chen, et al.
The Journal of Hospital Infection|May 17, 2002
Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factorsA Y H Leung, C S Chim, P L Ho, et al.
Internal Medicine Journal|January 3, 2013
Antifungal drug usage in haematologic patients during a 4-year period in an Asian university teaching hospitalT S Y Chan, Y-Y Hwang, H Gill, et al.
Oncogene|December 5, 2012
BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemiaC Xu, H Fu, L Gao, et al.
Leukemia|August 27, 2013
IMWG consensus on risk stratification in multiple myelomaW J Chng, A Dispenzieri, C-S Chim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 yearsW-Y Au, S-Y Ma, C-S Chim, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Leukemia|March 8, 2019
Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Leukemia|December 20, 2017
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Annals of Hematology|April 30, 2010
A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myelomaC S Chim, A K W Lie, E Y T Chan, et al.
Hematological Oncology|July 22, 1999
Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia: a single-centre experienceW Y Au, A K Lie, S K Ma, et al.
Chinese Medical Journal|June 1, 1997
Unrelated marrow donor registry for ChineseR Liang, C K Lee, F Chen, et al.
The Journal of Hospital Infection|May 17, 2002
Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factorsA Y H Leung, C S Chim, P L Ho, et al.
Internal Medicine Journal|January 3, 2013
Antifungal drug usage in haematologic patients during a 4-year period in an Asian university teaching hospitalT S Y Chan, Y-Y Hwang, H Gill, et al.
Oncogene|December 5, 2012
BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemiaC Xu, H Fu, L Gao, et al.
Leukemia|August 27, 2013
IMWG consensus on risk stratification in multiple myelomaW J Chng, A Dispenzieri, C-S Chim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 yearsW-Y Au, S-Y Ma, C-S Chim, et al.
Pageof 16